Showing results (11-20 of 810) with videos related to
Sort By:
Pageof 81
Digestive Diseases (Basel, Switzerland)|March 2, 2017
Nor-Ursodeoxycholic Acid as a Novel Therapeutic Approach for Cholestatic and Metabolic Liver DiseasesEmina Halilbasic, Daniel Steinacher, Michael TraunerJournal of Hepatology|August 14, 2012
Bile acid transporters and regulatory nuclear receptors in the liver and beyondEmina Halilbasic, Thierry Claudel, Michael TraunerClinics in Liver Disease|April 2, 2013
Nuclear receptors as drug targets in cholestatic liver diseasesEmina Halilbasic, Anna Baghdasaryan, Michael TraunerMolecular Aspects of Medicine|October 22, 2013
Chronic cholestatic liver diseases: clues from histopathology for pathogenesisMarion J Pollheimer, Peter Fickert, Bruno StiegerHepatology (Baltimore, Md.)|June 30, 2005
CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in miceMartin Wagner, Emina Halilbasic, Hanns-Ulrich Marschall, et al.Digestive Diseases (Basel, Switzerland)|June 23, 2016
Farnesoid X Receptor Agonists and Other Bile Acid Signaling Strategies for Treatment of Liver DiseaseEmina Halilbasic, Claudia Fuchs, Stefan Traussnigg, et al.Current Opinion in Gastroenterology|March 15, 2014
Fibrate treatment for primary biliary cirrhosisFrans J C Cuperus, Emina Halilbasic, Michael TraunerJournal of Hepatology|January 23, 2009
When lightning strikes twice: the plot thickens for a dual role of the anion exchanger 2 (AE2/SLC4A2) in the pathogenesis and treatment of primary biliary cirrhosisPeter Fickert, Michael TraunerHepatology (Baltimore, Md.)|December 21, 2016
New therapeutic concepts in bile acid transport and signaling for management of cholestasisMichael Trauner, Claudia Daniela Fuchs, Emina Halilbasic, et al.International Journal of Molecular Sciences|August 6, 2014
Cystic fibrosis related liver disease--another black box in hepatologyKatharina Staufer, Emina Halilbasic, Michael Trauner, et al.Pageof 81